Human defensin 5 expression in intestinal metaplasia of the upper gastrointestinal tract

Journal of Clinical Pathology

Volumn 58, Issue 7, 2005, Pages 687-694

  Shen, B ^b   Porter, E M ^c   Reynoso, E ^c   Shen, C ^e   Ghosh, D ^b   Connor, J T ^b   Drazba, J ^b   Rho, H K ^b   Gramlich, T L ^b   Li, R ^f   Ormsby, A H ^b   Sy, M S ^f   Ganz, T ^d   Bevins, C L ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c CALIFORNIA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e The People's Hospital of Qidong city   (China)

^f CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEFENSIN; HUMAN DEFENSIN 5; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBACTERIAL ACTIVITY; ARTICLE; BARRETT ESOPHAGUS; CANCER RISK; CELL GRANULE; CELL SPECIFICITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENDOSCOPIC BIOPSY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FEMALE; GASTRIC INTESTINAL METAPLASIA; GASTROESOPHAGEAL REFLUX; GENE EXPRESSION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; MUCOSAL IMMUNITY; PANETH CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPPER GASTROINTESTINAL TRACT; WESTERN BLOTTING;

ADULT; AGED; BARRETT ESOPHAGUS; BLOTTING, WESTERN; DEFENSINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESOPHAGOGASTRIC JUNCTION; FEMALE; GASTRIC MUCOSA; GENE EXPRESSION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METAPLASIA; MIDDLE AGED; PANETH CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 21844474072     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2004.022426     Document Type: Article

References (53)

1. Folk GW. Barrett's esophagus. Gastroenterology 2002;122:1569-91.
2. Goldblum JR, Richter JE, Vaezi M, et al. Helicobacter pylori infection, not gostroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa. Am J Gastroenterol 2002;97:302-11.
3. Spechler SJ, Zorrogian JM, Antonioli DA, et al. Prevalence of metaplasia at the gastro-osophageal junction. Lancet 1994;344:1533-6.
4. Sharma P, Morales TG, Bhattachayya A, et al. Dysplasia in short segment Borrett's esophagus: a prospective 3-year follow-up. Am J Gastroenterol 1997;92:2012-16.
5. Trudgill NJ, Suvarna SK, Kapur KC, et al. Intestinal metaplasia at the squamocolumnar junction in patients attending for diagnostic endoscopy. Gut 1997;41:585-9.
6. Hackelsberger A, Gunther T, Schultze V, et al. Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease? Gut 1998;43:17-21.
7. Hirota WK, Loughney TM, Lazas DJ, et al. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 1999;116:277-85.
8. Morales TG, Camargo E, Bhattacharyya A, et al. Long-term follow-up of intestinal metaplasia of the gastric cardia. Am J Gastroenterol 2000;95:1677-80.
9. Ormsby AH, Vaezi MF, Richter JE, et al. Cytokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett's esophagus. Gastroenterology 2000;119:683-90.
10. Rubio CA, Sugano H, Kitagawa T. Intestinal metaplasia of the stomach in Swedish and Japanese patients without ulcers or carcinoma. Jpn J Cancer Res 1987;78:467-72.
11. Rubio CA, Matthies M, Itabashi M, et al. Image quantitation of intestinal metaplasia in entire gastrectomy specimens from Swedish and Japanese patients. Jpn J Cancer Res 1996;87:711-17.
12. Silva S, Filipe MI, Pinho A. Variants of intestinal metaplasia in the evolution of chronic atrophic gastritis and gastric ulcer. A follow up study. Gut 1990;31:1097-104.
13. van Sandick JW, van Lanschot JB, van Felius L, et al. Intestinal metaplasia of the esophagus or esophagogastric junction: evidence of distinct clinical, pathologic, and histochemical staining features. Am J Clin Pathol 2002;117:117-25.
14. Schriber DS, Apstein M, Hermos JA. Paneth cells in Barrett's esophagus. Gastroenterology 1978;74:1302-4.
15. Rubio CA, Porwit-McDonald A, Rodensjo M, et al. A method of quantitating Paneth cell metaplasia of the stomach by image analysis. Anal Quant Cytal Histol 1989;11:115-18.
16. Porter EM, Bevins CL, Ghosh D, et al. The multifaceted Paneth cell. Cell Mol Life Sci 2002;59:156-70.
17. Porter E, Liu L, Oren A, et al. Localization of human intestinal defensin 5 in Paneth cell granules. Infect Immun 1997;65:2389-95.
18. Ayabe T, Satchell DP, Wilson CL, et al. Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat Immunol 2000;1:113-18.
19. Ghosh D, Porter EM, Shen B, et al. Paneth cell trypsin is the processing enzyme for human defensin-5. Nat Immunol 2002;3:583-90.
20. Peeters T, Vantrappen G. The Paneth cell: a source of intestinal lysozyme. Gut 1975;16:553-8.
21. Nevalainen TJ, Gronroos JM, Kallajoki M. Expression of group II phospholipase A2 in the human gastrointestinal tract. Lab Invest 1995;72:201-8.
22. Wilson CL, Ouellette AJ, Satchell DP, et al. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 1999;286:113-17.
23. Salzman NH, Ghosh D, Huttner KM, et al. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 2003;422:522-6.
24. Porter EM, Poles AM, Lee JS, et al. Isolation of human intestinal defensins from ileal neobladder urine. FEBS Lett 1998;434:272-6.
25. Cunliffe RN, Rose FR, Keyte J, et al. Human defensin 5 is stored in precursor form in normal Paneth cells and is expressed by some villous epithelial cells and by metaplastic Paneth cells in the colon in inflammatory bowel disease. Gut 2001;48:176-85.
26. Porter E, van Dam E, Valore E, et al. Broad spectrum antimicrobial activity of human intestinal defensin 5. Infect Immun 1997;65:2396-401.
27. Inada K, Tanaka H, Nakanishi H, et al. Identification of Paneth cells in pyloric glands associated with gastric and intestinal mixed-type intestinal metaplasia of the human stomach. Virchows Arch 2001;439:14-20.
28. Ayabe T, Satoh T, Watari J, et al. Ectopic Paneth cells in intestinal metaplasia of human stomach are capable of clearing Helicobacter pylori by microbicidal secretion. Gastroenterology 2002;122:A70.
29. Wong WM, Stamp GW, Elia G, et al. Proliferate populations in intestinal metaplasia: evidence of deregulation in Paneth and goblet cells, but not endocrine cells. J Pathol 2000;190:107-13.
30. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002;347:1175-86.
31. O'Neil DA, Cole SP, Mortin-Porter E, et al. Regulation of human beta-defensins by gastric epithelial cells in response to infection with Helicobacter pylori or stimulation with interleukin-1. Infect Immun 2000;68:5412-15.
32. Hamanaka Y, Nakashima M, Wada A, et al. Expression of human beta-defensin 2 (hBD-2) in Helicobacter pylori induced gastritis: antibacterial effect of hBD-2 against Helicobacter pylori. Gut 2001;49:481-7.
33. Bajaj-Elliott M, Fedeli P, Smith GV, et al. Modulation of host antimicrobial peptide (beta-defensins 1 and 2) expression during gastritis. Gut 2002;51:356-61.
34. Hase K, Murakami M, Iimura M, et al. Expression of LL-37 by human gastric epithelial cells as a potential host defense mechanism against Helicobacter pylori. Gastroenterology 2003;125:1613-25.
35. George JT, Boughan PK, Karageorgiou H, et al. Host anti-microbial response to Helicobacter pylori infection. Mol Immunol 2003;40:451-6.
36. Wehkamp J, Schmidt K, Herrlinger KR, et al. Defensin pattern in chronic gastritis: HBD-2 is differentially expressed with respect to Helicobacter pylori status. J Clin Pathol 2003;56:352-7.
37. Harlow E, Lane D. Antibodies: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1988.
38. Hertz CJ, Wu Q, Porter EM, et al. Activation of Toll-like receptor 2 on human tracheobronchial epithelial cells induces the antimicrobial peptide human beta defensin-2. J Immunol 2003;171:6820-6.
39. Janes DE, Bevins CL. Paneth cells of the human small intestine express an antimicrobial peptide gene. J Biol Chem 1992;267:23216-25.
40. Chirgwin JM, Pryzybyla AE, MacDonald RJ, et al. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979;18:5294-9.
41. Elmes ME, Jones JG, Stanton MR. Changes in the Paneth cell population of human small intestine assessed by image analysis of the secretory granule area. J Clin Pathol 1983;36:867-72.
42. Ouellette A, Bevins CL. Paneth cell defensins and innate immunity of the small bowel. Inflamm Bowel Dis 2001;7:43-50.
43. Cunliffe RN, Mahida YR. Expression and regulation of antimicrobial peptides in the gastrointestinal tract. J Leukoc Biol 2004;75:49-58.
44. Thompson AB, Bohling T, Payvandi F, et al. Lower respiratory tract lactoferrin and lysozyme arise primarily in the airways and are elevated in association with chronic bronchitis. J Lab Clin Med 1990;115:148-58.
45. Coutinho HB, Robalinho TI, Coutinho VB, et al. Immunocytochemical demonstration that human duodenal Brunner's glands may participate in intestinal defence. J Anat 1 996;189:193-7.
46. Quayle AJ, Porter EM, Nussbaum AA, et al. Gene expression, immunolocalization and secretion of human defensin-5 in human female reproductive tract. Am J Pathol 1998;152:1247-58.
47. Qu XD, Lehrer RI. Secretory phospholipase A2 is the principal bactericide for staphylococci and other Gram-positive bacteria in human tears. Infect Immun 1998;66:2791-7.
48. Chen FS, Scher DM, Clancy RM, et al. In vitro and in vivo activation of polymorphonuclear leukocytes in response to particulate debris. J Biomed Mater Res 1999;48:904-12.
49. Shen B, Ormsby AH, Shen C, et al. Cytokeratin expression patterns in noncardia, intestinal metaplasia-associated gastric adenocarcinoma: implication for the evaluation of intestinal metaplasia and tumors at the esophagogastric junction. Cancer 2002;94:820-31.
50. Lord RVN, Frommer DJ, Inder S, et al. Prevalence of Helicobacter pylori infection in 160 patients with Barrett's oesophagus or Barrett's adenocarcinoma. Aust N Z J Surg 2002;70:26-33.
51. El-Serag HB, Sonnenberg AG. Opposing time trends of peptic ulcer and reflux disease. Gut 1999;43:327-33.
52. Chow WH, Blaser MJ, Blot WJ, et al. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 1998;58:588-90.
53. Forsberg G, Fahlgren A, Horstedt P, et al. Presence of bacteria and innate immunity of intestinal epithelium in childhood celiac disease. Am J Gastroenterol 2004;99:894-904.